JM
JP Morgan Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
2051
Frontdoor
FTDR
$4.75B
|
DA
Doug Anmuth
| $65.34 | $46 |
30%
downside
| Overweight |
18 Mar ‘20
5 years ago |
|
2052
EverQuote
EVER
$866M
|
DA
Doug Anmuth
| $24.31 | $39 |
60%
upside
| Overweight |
18 Mar ‘20
5 years ago |
|
2053
BioNTech
BNTX
$24.5B
|
CK
Cory Kasimov
| $102.09 | $33 |
68%
downside
| Neutral |
18 Mar ‘20
5 years ago |
|
2054
Hologic
HOLX
$14.8B
|
TP
Tycho Peterson
| $66.72 | $50 |
25%
downside
| Overweight |
17 Mar ‘20
5 years ago |
|
2055
Goldman Sachs
GS
$231B
| $763.92 | $210 |
73%
downside
| Overweight |
17 Mar ‘20
5 years ago |
|
|
2056
Dentsply Sirona
XRAY
$2.77B
|
TP
Tycho Peterson
| $13.91 | $45 |
224%
upside
| Neutral |
17 Mar ‘20
5 years ago |
|
2057
Cinemark Holdings
CNK
$3.16B
|
AQ
Alexia Quadrani
| $27.01 | $20 |
26%
downside
| Neutral |
17 Mar ‘20
5 years ago |
|
2058
IMAX
IMAX
$1.67B
|
AQ
Alexia Quadrani
| $30.68 | $15 |
51%
downside
| Neutral |
17 Mar ‘20
5 years ago |
|
|
NBIS
2059
Nebius Group N.V. Class A Ordinary Shares
NBIS
$22.8B
|
AG
Alexei Gogolev
| $95.72 | $51 |
47%
downside
| Overweight |
11 Mar ‘20
5 years ago |
|
2060
Takeda Pharmaceutical
TAK
$48.2B
| $15.27 | $30 |
96%
upside
| Overweight |
11 Mar ‘20
5 years ago |
|
|
2061
Kiniksa Pharmaceuticals
KNSA
$2.73B
| $36.86 | $24 |
35%
downside
| Overweight |
11 Mar ‘20
5 years ago |
|
|
2062
EPAM Systems
EPAM
$9.19B
|
AG
Alexei Gogolev
| $165.02 | $249 |
51%
upside
| Overweight |
11 Mar ‘20
5 years ago |
|
2063
TTM Technologies
TTMI
$4.92B
|
PC
Paul Coster
| $47.60 | $15 |
68%
downside
| Neutral |
11 Mar ‘20
5 years ago |
|
2064
VEON
VEON
$3.73B
|
AG
Alexei Gogolev
| $53.91 | $55 |
2%
upside
| Neutral |
11 Mar ‘20
5 years ago |
|
|
INVX
2065
Innovex International, Inc.
INVX
$1.14B
|
SM
Sean Meakim
| $16.30 | $39 |
139%
upside
| Overweight |
10 Mar ‘20
5 years ago |
|
2066
Realty Income
O
$54.4B
| $59.49 | $79 |
33%
upside
| Neutral |
9 Mar ‘20
5 years ago |
|
|
2067
Ionis Pharmaceuticals
IONS
$10.3B
| $64.40 | $60 |
7%
downside
| Neutral |
9 Mar ‘20
5 years ago |
|
|
2068
Virtu Financial
VIRT
$3.22B
|
KW
Ken Worthington
| $38.05 | $23 |
40%
downside
| Overweight |
4 Mar ‘20
5 years ago |
|
2069
Rexford Industrial Realty
REXR
$10.2B
| $42.72 | $49 |
15%
upside
| Neutral |
4 Mar ‘20
5 years ago |
|
|
2070
UDR
UDR
$12.8B
| $38.98 | $51 |
31%
upside
| Overweight |
3 Mar ‘20
5 years ago |
|
|
2071
JD.com
JD
$48B
| $33.87 | $52 |
54%
upside
| Overweight |
3 Mar ‘20
5 years ago |
|
|
2072
Galapagos
GLPG
$2.21B
| $32.67 | $200 |
512%
upside
| Neutral |
2 Mar ‘20
5 years ago |
|
|
2073
iQIYI
IQ
$2.69B
| $2.79 | $23 |
724%
upside
| Neutral |
2 Mar ‘20
5 years ago |
|
|
2074
GE Aerospace
GE
$293B
|
ST
Stephen Tusa
| $276.24 | $64 |
77%
downside
| Neutral |
2 Mar ‘20
5 years ago |
|
2075
Marriott International Class A Common Stock
MAR
$72.8B
| $264 | $129 |
51%
downside
| Neutral |
28 Feb ‘20
5 years ago |
|